Asilomar Conference on Mass Spectrometry
\n
Metabolite Profiling: Biomarker Discovery, Drug Efficacy and Fundamental Biochemistry
\n
October 15 – 19, 2004
\n<\/p>\n
“Metabolites have gained increasing interest over the past five years largely
\n
for their implications in diagnostic and pharmaceutical biomarker discovery.
\n
Although numerous small molecules are routinely measured in biofluids as indicators
\n
of health little is known about the vast majority of metabolites. For example,
\n
biofluids contain thousands of components many of which remain structurally and
\n
functionally uncharacterized. For this reason metabolite research and its potential
\n
in health and pharmaceutical development has become one of the most exciting
\n
areas of biological discovery. Three of the broad aims of this field are to identify
\n
new disease biomarkers, monitor physiological reactions to administered drugs
\n
and to understand the function of metabolites. This Asilomar meeting will focus
\n
on the latest challenges in metabolite profiling spanning a broad range of interests
\n
including research trends and instrument developments.”<\/cite><\/p><\/blockquote>\nIf you are interested in participating as a speaker, please contact Gary Siuzdak<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"
Asilomar Conference on Mass Spectrometry Metabolite Profiling: Biomarker Discovery, Drug Efficacy and Fundamental Biochemistry October 15 – 19, 2004 “Metabolites have gained increasing interest over the past five years largely for their implications in diagnostic and pharmaceutical biomarker discovery. Although numerous small molecules are routinely measured in biofluids as indicators of health little is known … <\/p>\n